Member access

4-Traders Homepage  >  Shares  >  SHENZHEN STOCK EXCHANGE  >  Beijing SL Pharmaceutical Co Ltd    002038   CNE000001L31

No quotes available
-- CNY   --.--%
08/20 BEIJING SL PHARMACEUTICAL : H1 Net Up 22%
04/28 BEIJING SL PHARMACEUTICAL : SL Pharmaceutical 2013 Net Up 20.04%
SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Produces and supplies pharmaceutical products

Beijing SL Pharmaceutical Co. Ltd. engages in the development and marketing gene engineering drugs.

Its products include Li Sheng Su, a recombinant human Granulocyte Colony-stimulating Factor (rhG-CSF) injection; Mai Ge Er, a recombinant human Interleukin-11 (rhIL-11) injection; and Xin Ji Er, a recombinant human Ala Interleukin-2 (Ala IL-2) injection.

The company was founded by Ming Bo Xu in December 1994 and is headquartered in Beijing, China.

Number of employees : 637 persons.
Sales per Businesses
20122013Delta
CNY (in Million)%CNY (in Million)%
Biochemical Medicine822.9081.8%981.0284.5% +16.12%
Chemistry Medicine128.9412.8%131.5311.3% +1.97%
Other Service Income55.185.5%35.003% -57.68%
Other--14.231.2%-
Sales per Regions
20122013Delta
CNY (in Million)%CNY (in Million)%
China1,006100%1,161100% +13.33%
Managers
NameAgeSinceTitle
Mingbo Xu, PhD50-Chairman & President
Anjing Lu57-Chairman-Supervisory Board
Wenying Xi51-Chief Financial Officer
Yu Lin Chen69-Director
Xiu Jiang Wen37-Director-Supervisory Board
Qing Jun Ma78-Independent Director
Su Yan Wei, CPA62-Independent Director
Ming Xi Zhang, CPA442007Independent Director
Shujie Liang48-Board Secretary
Yong Bo Wang39-Vice President
Shareholders
NameShares%
Xinxiang State Owned Asset Sup. & Adm. Commssion 96,643,72925.8%
Mingbo Xu, PhD 25,743,5016.86%
China International Fund Management Co., Ltd. 12,095,8893.23%
China Resources SZITIC Trust Co., Ltd. 10,100,0442.69%
E Fund Management Co., Ltd. 8,950,6692.39%
Harvest Fund Management Co., Ltd. 8,661,0372.31%
Bin Wang 5,479,1001.46%
Fortune SG Fund Management Co., Ltd. 5,398,1441.44%
China Universal Asset Management Co., Ltd. 4,932,5851.32%
Penghua Fund Management Co., Ltd. 4,880,2201.30%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Advertisement
Surperformance© rating
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation -
Finances -
Profitability
Earnings quality
Business Predictability
PER
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
More Ratings
Sector Biotechnology & Medical Research
Growth (Revenue) Profitability
ACTELION LTD
SHANGHAI RAAS BLO..
-
MEDIVATION INC
INTERCEPT PHARMAC..
HUALAN BIOLOGICAL..
BEIJING SL PHARMA..
NPS PHARMACEUTICA..
AGIOS PHARMACEUTI..
RECEPTOS INC
TONGHUA DONGBAO P..
AVANIR PHARMACEUT..
GENMAB A/S
MANNKIND CORPORAT..
CLOVIS ONCOLOGY I..
DYAX CORP.
KERYX BIOPHARMACE..
CHINA BIOLOGIC PR..
GW PHARMACEUTICAL..
BIOCON LTD
ACORDA THERAPEUTI..
Sector Biotechnology & Medical Research
Company contact information
Beijing SL Pharmaceutical Co., Ltd.
9 Zhongyuan Road
Bada High Development District
Beijing 100041

Phone : +86.10.8879.9370
Fax : +86.10.8879.5883
Web : www.slpharm.com.cn
© 2014 Factset   
Dynamic quotes  
ON
| OFF